Tuesday, 17 November 2026European Markets

NYXOAH Stock Impressive Slide 10% So Far On Wednesday, Underperforms Market

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - Shares of NYXOAH (BEL 20: NYXH.BR) fell by a staggering 10.8% to €7.10 at 14:22 EST on Wednesday, after three consecutive sessions in a row of losses. BEL 20 is dropping 0.51% to €3,806.44, following the last session's downward trend. This seems, up to now, a somewhat negative trend exchanging session today.

NYXOAH's last close was €7.96, 53.5% under its 52-week high of €17.12.

About NYXOAH

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Earnings Per Share

As for profitability, NYXOAH has a trailing twelve months EPS of €-1.1.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -23.22%.

More news about NYXOAH (NYXH.BR).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

  1. Published before we listed source documents with each article.
  2. Published 26 Apr 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›